• Health & Medicine

Artificial intelligence could help breast screening save more lives

We’ve helped Google Health with AI research which has the potential to improve breast cancer screening and save the NHS time and money. We’ve helped Google Health with AI research which has the potential to improve breast cancer screening and save the NHS time and money.

1 January 2020

• Science & Technology
• Health & Medicine

News digest – prostate cancer MRI trial, drug delivery, cancer ‘cures’ on Facebook and weight loss

In the news this week: WHO approves a cheap copy of a common breast cancer drug that could save the lives of women in low income countries. In the news this week: WHO approves a cheap copy of a common breast cancer drug that could save the lives of women in low income countries.

21 December 2019

• For Supporters

In conversation with our Chair, Sir Borys – Part two: From lab to leadership

Professor Sir Leszek Borysiewicz, speaks about how a diverse CV has helped him navigate chairmanship of the world’s largest cancer charity Professor Sir Leszek Borysiewicz, speaks about how a diverse CV has helped him navigate chairmanship of the world’s largest cancer charity

20 December 2019

• For Researchers

Richard Martin: How to write an award-winning population research funding proposal

Richard Martin, leader of the CRUK-funded CAP trial of prostate cancer screening, spoke to us about the study’s impact and his advice for funding applicants. Richard Martin, leader of the CRUK-funded CAP trial of prostate cancer screening, spoke to us about the study’s impact and his advice for funding applicants.

19 December 2019

• Science & Technology
• Health & Medicine

Our biggest cancer news stories of 2019

We look back at the top cancer news stories of 2019, including the first trial of a cancer breath test. We look back at the top cancer news stories of 2019, including the first trial of a cancer breath test.

17 December 2019

• Science & Technology

First-in-human trial for new lung cancer immunotherapy

Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer

17 December 2019

• Science & Technology
• Health & Medicine

News digest – NHS drug decisions, leukaemia treatment trials and long term anastrozole benefits

In the news this week: breast cancer drug combo made more widely available on the NHS and the long term benefits of anastrozole are revealed. In the news this week: breast cancer drug combo made more widely available on the NHS and the long term benefits of anastrozole are revealed.

14 December 2019

• For Supporters

In conversation with our Chair, Sir Borys - Finding answers to the whys

In the first of a two-part interview, we chart the remarkable journey to knighthood of Chair of Cancer Research UK, Professor Sir Leszek Borysiewicz. In the first of a two-part interview, we chart the remarkable journey to knighthood of Chair of Cancer Research UK, Professor Sir Leszek Borysiewicz.

13 December 2019

• Health & Medicine

Blood test can quickly match advanced breast cancer patients to targeted treatments

New trial results show that a blood test can identify rare types of advanced breast cancer and help patients to access the right treatment more quickly. New trial results show that a blood test can identify rare types of advanced breast cancer and help patients to access the right treatment more quickly.

12 December 2019

• Health & Medicine

Targeted ovarian cancer drug made available to more people on NHS in England

NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England. NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.

11 December 2019

• For Supporters

The rise and rise of our ScottishPower partnership

How a £5m fundraising target grew to over £25m raised towards beating cancer, united employees and engaged more than 500,000 customers How a £5m fundraising target grew to over £25m raised towards beating cancer, united employees and engaged more than 500,000 customers

9 December 2019

• Health & Medicine

Targeted ovarian cancer drug made more widely available on the NHS in Scotland

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy. A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.

9 December 2019